Fundraising FoxExcel Venture Management — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
MetaVia is a clinical-stage biotechnology company developing therapeutics for cardiometabolic diseases, including DA-1726 for obesity and vanoglipel (DA-1241) for Metabolic Dysfunction-Associated Steatohepatitis (MASH).
BiotechHealthtechCambridge, US
Mina Sooch(Executive Officer)Hyung Heon Kim(Executive Officer, Director)Margaret McShane(Executive Officer)David Lowenschuss(Executive Officer)Marshall Woodworth(Chief Financial Officer)Charles Bisgaier(Executive Officer)
Board seatSteve Gullans· per SEC Form D · $12.5M raise · filed Mar 2017
Co-investorsGREAT LAKES BAY VENTURE
Wellbox provides nurse-delivered chronic care management (CCM) services, offering monthly patient interactions and preventative care support for individuals with multiple chronic conditions.
Digital HealthHealthtechJacksonville, US
Nathaniel B. Findlay(Executive Officer)
BoardMatthew Downs(Director)Vincent Chiara(Director)Nashaat Daniel(Director)Ian Ihnatowycz(Director)Leonard B.C. Schlemm(Director)
Co-investorsBeresford VenturesExcelerate Health VenturesLRVHealthTamiami AngelVentureSouth
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.